Cargando…
Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis
We examine the microstructure of liquidity provision in the COVID-19 corporate bond liquidity crisis. During the two weeks leading up to Federal Reserve System interventions, volume shifted to liquid securities, transaction costs soared, trade-size pricing inverted, and dealers, particularly non-pri...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759631/ https://www.ncbi.nlm.nih.gov/pubmed/36568646 http://dx.doi.org/10.1016/j.jfineco.2021.05.052 |
_version_ | 1784852274140413952 |
---|---|
author | O'Hara, Maureen Zhou, Xing (Alex) |
author_facet | O'Hara, Maureen Zhou, Xing (Alex) |
author_sort | O'Hara, Maureen |
collection | PubMed |
description | We examine the microstructure of liquidity provision in the COVID-19 corporate bond liquidity crisis. During the two weeks leading up to Federal Reserve System interventions, volume shifted to liquid securities, transaction costs soared, trade-size pricing inverted, and dealers, particularly non-primary dealers, shifted from buying to selling, causing dealers’ inventories to plummet. Liquidity provisions in electronic customer-to-customer trading increased, though at prohibitively high costs. By improving dealer funding conditions and providing a liquidity backstop, the Primary Dealer Credit Facility and the Secondary Market Corporate Credit Facility (SMCCF) stabilized trading conditions. Most of the impact of SMCCF on bond liquidity seems to have materialized following its announcement. We argue that the Federal Reserve's actions reflect a new role as market maker of last resort. |
format | Online Article Text |
id | pubmed-9759631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97596312022-12-19 Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis O'Hara, Maureen Zhou, Xing (Alex) J financ econ Article We examine the microstructure of liquidity provision in the COVID-19 corporate bond liquidity crisis. During the two weeks leading up to Federal Reserve System interventions, volume shifted to liquid securities, transaction costs soared, trade-size pricing inverted, and dealers, particularly non-primary dealers, shifted from buying to selling, causing dealers’ inventories to plummet. Liquidity provisions in electronic customer-to-customer trading increased, though at prohibitively high costs. By improving dealer funding conditions and providing a liquidity backstop, the Primary Dealer Credit Facility and the Secondary Market Corporate Credit Facility (SMCCF) stabilized trading conditions. Most of the impact of SMCCF on bond liquidity seems to have materialized following its announcement. We argue that the Federal Reserve's actions reflect a new role as market maker of last resort. Elsevier B.V. 2021-10 2021-06-01 /pmc/articles/PMC9759631/ /pubmed/36568646 http://dx.doi.org/10.1016/j.jfineco.2021.05.052 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article O'Hara, Maureen Zhou, Xing (Alex) Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis |
title | Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis |
title_full | Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis |
title_fullStr | Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis |
title_full_unstemmed | Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis |
title_short | Anatomy of a liquidity crisis: Corporate bonds in the COVID-19 crisis |
title_sort | anatomy of a liquidity crisis: corporate bonds in the covid-19 crisis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759631/ https://www.ncbi.nlm.nih.gov/pubmed/36568646 http://dx.doi.org/10.1016/j.jfineco.2021.05.052 |
work_keys_str_mv | AT oharamaureen anatomyofaliquiditycrisiscorporatebondsinthecovid19crisis AT zhouxingalex anatomyofaliquiditycrisiscorporatebondsinthecovid19crisis |